These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 25199458)

  • 1. PARP and other prospective targets for poisoning cancer cell metabolism.
    Michels J; Obrist F; Castedo M; Vitale I; Kroemer G
    Biochem Pharmacol; 2014 Nov; 92(1):164-71. PubMed ID: 25199458
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) induces oxidative stress, DNA strand breaks, and poly(ADP-ribose) polymerase-1 activation in human breast carcinoma cell lines.
    Lin PH; Lin CH; Huang CC; Chuang MC; Lin P
    Toxicol Lett; 2007 Aug; 172(3):146-58. PubMed ID: 17669606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction of ROS formation, poly(ADP-ribose) polymerase-1 activation, and cell death by PCB126 and PCB153 in human T47D and MDA-MB-231 breast cancer cells.
    Lin CH; Lin PH
    Chem Biol Interact; 2006 Aug; 162(2):181-94. PubMed ID: 16884709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Platinated benzonaphthyridone is a stronger inhibitor of poly(ADP-ribose) polymerase-1 and a more potent anticancer agent than is the parent inhibitor.
    Wang B; Qian H; Yiu SM; Sun J; Zhu G
    Eur J Med Chem; 2014 Jan; 71():366-73. PubMed ID: 24361480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disparity in the induction of glutathione depletion, ROS formation, poly(ADP-ribose) polymerase-1 activation, and apoptosis by quinonoid derivatives of naphthalene in human cultured cells.
    Lin CH; Huang CC; Wang TW; Wang YJ; Lin PH
    Chem Biol Interact; 2007 Feb; 165(3):200-10. PubMed ID: 17224139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of PARP-1 and PARP-2 enzymes in metabolic regulation and disease.
    Bai P; Cantó C
    Cell Metab; 2012 Sep; 16(3):290-5. PubMed ID: 22921416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-NAD-Like poly(ADP-Ribose) Polymerase-1 Inhibitors effectively Eliminate Cancer in vivo.
    Thomas C; Ji Y; Lodhi N; Kotova E; Pinnola AD; Golovine K; Makhov P; Pechenkina K; Kolenko V; Tulin AV
    EBioMedicine; 2016 Nov; 13():90-98. PubMed ID: 27727003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PARP inhibitors for anticancer therapy.
    Curtin N
    Biochem Soc Trans; 2014 Feb; 42(1):82-8. PubMed ID: 24450632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [PARP inhibitors for cancer therapy].
    Saito H; Miki Y
    Gan To Kagaku Ryoho; 2011 Jan; 38(1):12-8. PubMed ID: 21368455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PARP inhibitors: new partners in the therapy of cancer and inflammatory diseases.
    Peralta-Leal A; Rodríguez-Vargas JM; Aguilar-Quesada R; Rodríguez MI; Linares JL; de Almodóvar MR; Oliver FJ
    Free Radic Biol Med; 2009 Jul; 47(1):13-26. PubMed ID: 19362586
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyridine nucleotide cycling and control of intracellular redox state in relation to poly (ADP-ribose) polymerase activity and nuclear localization of glutathione during exponential growth of Arabidopsis cells in culture.
    Pellny TK; Locato V; Vivancos PD; Markovic J; De Gara L; Pallardó FV; Foyer CH
    Mol Plant; 2009 May; 2(3):442-56. PubMed ID: 19825628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adipose tissue NAD
    Jokinen R; Pirnes-Karhu S; Pietiläinen KH; Pirinen E
    Redox Biol; 2017 Aug; 12():246-263. PubMed ID: 28279944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of nitric oxide on naphthoquinone toxicity in endothelial cells: role of bioenergetic dysfunction and poly (ADP-ribose) polymerase activation.
    Broniowska KA; Diers AR; Corbett JA; Hogg N
    Biochemistry; 2013 Jun; 52(25):4364-72. PubMed ID: 23718265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeine metabolites are inhibitors of the nuclear enzyme poly(ADP-ribose)polymerase-1 at physiological concentrations.
    Geraets L; Moonen HJ; Wouters EF; Bast A; Hageman GJ
    Biochem Pharmacol; 2006 Sep; 72(7):902-10. PubMed ID: 16870158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation.
    Bai P; Cantó C; Oudart H; Brunyánszki A; Cen Y; Thomas C; Yamamoto H; Huber A; Kiss B; Houtkooper RH; Schoonjans K; Schreiber V; Sauve AA; Menissier-de Murcia J; Auwerx J
    Cell Metab; 2011 Apr; 13(4):461-468. PubMed ID: 21459330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive biomarkers for cancer therapy with PARP inhibitors.
    Michels J; Vitale I; Saparbaev M; Castedo M; Kroemer G
    Oncogene; 2014 Jul; 33(30):3894-907. PubMed ID: 24037533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of 1-substituted benzyl-quinazoline-2,4(1H,3H)-dione derivatives as novel poly(ADP-ribose)polymerase-1 inhibitors.
    Yao H; Ji M; Zhu Z; Zhou J; Cao R; Chen X; Xu B
    Bioorg Med Chem; 2015 Feb; 23(4):681-93. PubMed ID: 25614115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iniparib nonselectively modifies cysteine-containing proteins in tumor cells and is not a bona fide PARP inhibitor.
    Liu X; Shi Y; Maag DX; Palma JP; Patterson MJ; Ellis PA; Surber BW; Ready DB; Soni NB; Ladror US; Xu AJ; Iyer R; Harlan JE; Solomon LR; Donawho CK; Penning TD; Johnson EF; Shoemaker AR
    Clin Cancer Res; 2012 Jan; 18(2):510-23. PubMed ID: 22128301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of malignant phenotype and bioenergetics by a π-electron donor-inducible mitochondrial MgATPase.
    Kun E; Mendeleyev J; Kirsten E; Hakam A; Kun AM; Fekete A; Bauer PI; Dunai Z; Mihalik R
    Int J Mol Med; 2011 Feb; 27(2):181-6. PubMed ID: 21125212
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NAD+ as a metabolic link between DNA damage and cell death.
    Ying W; Alano CC; Garnier P; Swanson RA
    J Neurosci Res; 2005 Jan 1-15; 79(1-2):216-23. PubMed ID: 15562437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.